Cargando…

Healthcare reform in the United States and China: pharmaceutical market implications

OBJECTIVES: The United States and China are broadening health insurance coverage and increasing spending on pharmaceuticals, in contrast to other major economies that are reducing health spending and implementing a variety of drug price controls. This article analyzes the implications of health syst...

Descripción completa

Detalles Bibliográficos
Autores principales:	Daemmrich, Arthur, Mohanty, Ansuman
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4117976/ https://www.ncbi.nlm.nih.gov/pubmed/25097759 http://dx.doi.org/10.1186/2052-3211-7-9

Ejemplares similares

The political economy of healthcare reform in China: negotiating public and private
por: Daemmrich, Arthur
Publicado: (2013)

The impact of sanction and healthcare system reform on the healthcare performance and pharmaceutical market in Iran; 2001-2016
por: Zartab, Saman, et al.
Publicado: (2020)

The Evolving Hospital Market in China After the 2009 Healthcare Reform
por: Jiang, Qingling, et al.
Publicado: (2020)

Agricultural policy reforms: Roles of markets and states in China and India
por: Lele, Uma, et al.
Publicado: (2020)

The challenges of healthcare reforms in China
por: Li, L.
Publicado: (2011)

China's Pharmaceutical Market: Business Environment and Market Dynamics
por: Brueckner, Michael, et al.
Publicado: (2005)

De-Globalization, Welfare State Reforms and Labor Market Outcomes
por: Molana, Hassan, et al.
Publicado: (2021)

Remarks on the Reform of the Pharmaceutical Nomenclature
Publicado: (1808)

A Tale of Two Systems: Health Reform in China and the United States
por: Congdon, Nathan G., et al.
Publicado: (2010)

Does the leading pharmaceutical reform in China really solve the issue of overly expensive healthcare services? Evidence from an empirical study
por: He, Yunzhen, et al.
Publicado: (2018)

Healthcare reform: implications for knowledge translation in primary care
por: Dadich, Ann, et al.
Publicado: (2013)

The limits of market-based reforms
por: Dickinson, Helen, et al.
Publicado: (2013)

Redefining Health: Implication for Value-Based Healthcare Reform
por: Putera, Ikhwanuliman
Publicado: (2017)

Public satisfaction with health system after healthcare reform in China
por: Kang, Lili, et al.
Publicado: (2023)

Constitutional Reform by Legal Transplantation: The United Kingdom Internal Market Act 2020
por: Horsley, Thomas
Publicado: (2022)

Drug repurposing in pharmaceutical industry and its impact on market access: market access implications
por: Murteira, Susana, et al.
Publicado: (2014)

The impact of healthcare reform on the efficiency of public county hospitals in China
por: Jiang, Shuai, et al.
Publicado: (2017)

An Empirical Study on the Inequality in Health and Healthcare in China's Medical Reform
por: Li, Jing-wei, et al.
Publicado: (2022)

Pharmaceutical patenting in the European Union: reform or riddance
por: Garattini, Livio, et al.
Publicado: (2021)

International reference pricing of pharmaceuticals in the United States: Implications for potentially curative treatments
por: Sullivan, Sean D, et al.
Publicado: (2022)

Reforming for trust and professionalism in municipal healthcare services: implications for human resource management
por: Øygarden, Olaug, et al.
Publicado: (2023)

The European influence on workers' compensation reform in the United States
por: LaDou, Joseph
Publicado: (2011)

Gender-Affirming Health Insurance Reform in the United States
por: Ngaage, Ledibabari M., et al.
Publicado: (2020)

Cycles of reform in the history of psychosis treatment in the United States
por: George, Preethy, et al.
Publicado: (2023)

Health care policy and market reforms in Japan
por: Hori, Manami
Publicado: (2014)

Premium Rebates and the Quiet Consensus on Market Reform for Medicare
por: Feldman, Roger, et al.
Publicado: (2001)

Healthcare Reform and the Next Generation: United States Medical Student Attitudes toward the Patient Protection and Affordable Care Act
por: Huntoon, Kristin M., et al.
Publicado: (2011)

Reforms: a quest for efficiency or an opportunity for vested interests’? a case study of pharmaceutical policy reforms in Tanzania
por: Mori, Amani Thomas, et al.
Publicado: (2013)

Pharmaceutical Sales Representatives in the United States and China: The Need for Professional Public Space
por: Chen, Xiaoying
Publicado: (2021)

Can power market reform reduce air pollution?——Evidence from prefecture-level cities in China
por: Li, Xing, et al.
Publicado: (2023)

Trend analysis of the pharmaceutical market in Iran; 1997–2010; policy implications for developing countries
por: Kebriaeezadeh, Abbas, et al.
Publicado: (2013)

Peculiarity of Pharmaceutical Marketing in Serbia
por: Dickov, Veselin
Publicado: (2015)

Trends in Iran Pharmaceutical Market
por: Cheraghali, Abdol Majid
Publicado: (2017)

Pharmaceutical innovation and access to financial markets
por: Blau, Benjamin M., et al.
Publicado: (2022)

An economic analysis of the limits of market based reforms in the English NHS
por: Allen, Pauline
Publicado: (2013)

Drug reformulations and repositioning in the pharmaceutical industry and their impact on market access: regulatory implications
por: Murteira, Susana, et al.
Publicado: (2014)

Healthcare Reform ≠ Public Health Reform: On Pathogens, Poverty, and Prevention
por: Levin, Jeff
Publicado: (2018)

Impact of healthcare reform on the payer mix among young adult emergency department utilizers across the United States (2005–2015)
por: Bush, Haley, et al.
Publicado: (2018)

Education level of farmers, market-oriented reforms, and the utilization efficiency of agricultural water resources in China
por: Zhang, Ming, et al.
Publicado: (2023)

The United States' Health Care Reform Bill - A Translation
por: Quenell, Gregory
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_oislh5qc6n0acis42rkt9vlsaq